SCHEMBL8699645

SCHEMBL8699645

CCOC(=O)c1ccc(-c2ccccc2O)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.59
CA1 P00915 3/20 0.59
CA2 P00918 3/20 0.59
CA7 P43166 3/20 0.59
CA9 Q16790 3/20 0.59
CA14 Q9ULX7 3/20 0.59
ESR1 P03372 1/20 0.59
ESR2 Q92731 1/20 0.59
SMN1; SMN2 Q16637 5/20 0.55
MAPT P10636 3/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
HPGD P15428 2/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CYP1A2 P05177 2/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAOA P21397 1/20 0.53
KDM4E B2RXH2 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9608405 0.87 MEN1 (0.62) CA12CA1CA2CA7CA9
SCHEMBL2008250 0.85 CA12 (0.56) CA12CA1CA2CA7CA9
SCHEMBL5924878 0.83 F2RL3 (0.53) CA12CA1CA2CA7CA9
SCHEMBL11101131 0.83 MAPT (0.56) CA12CA1CA2CA7CA9
SCHEMBL282384 0.83 CA12 (0.53) CA12CA1CA2CA7CA9
SCHEMBL5654036 0.83 CYP1A2 (0.60) CA12CA1CA2CA7CA9
SCHEMBL9488109 0.83 CA12 (0.66) CA12CA1CA2CA7CA9
SCHEMBL2035147 0.81 EGFR (0.71) CA12CA1CA2CA7CA9
SCHEMBL4146550 0.81 MAPT (0.55) CA12CA1CA2CA7CA9
Hydrochloric Acid SCHEMBL9007650 0.81 CA12 (0.51) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101087752-B Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics GALDERMA RES & DEV 2011-11-16 CN disclosed
CN-101087752-A Novel ligands that modulate RAR receptors, and use thereof in human medicine and in cosmetics GALDERMA RES & DEV (FR) 2007-12-12 CN disclosed
WO-1998007716-A2 HETEROAROTINOIDS-ANTICANCER AGENTS WITH RECEPTOR SPECIFICITY AND TGASE ACTIVITY THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) 1998-02-26 WO disclosed
EP-0228703-B1 FERROELECTRIC LIQUID CRYSTAL POLYMER IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-03-10 EP disclosed
EP-0228703-A2 Ferroelectric liquid crystal polymer IDEMITSU KOSAN COMPANY LIMITED (JP) 1987-07-15 EP disclosed